Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol

被引：0
|
作者：
Matthias Uhl
Lutz Edler
Alexandra D Jensen
Gregor Habl
Jan Oelmann
Falk Röder
Oliver Jäckel
Jürgen Debus
Klaus Herfarth
机构：
[1] University of Heidelberg,Department of Radiation Oncology
[2] Heidelberg Ion Therapy Center (HIT),undefined
[3] German Cancer Research Center (dkfz),undefined
来源：
Radiation Oncology | / 9卷
关键词：
Sacral chordoma; Chordoma; Carbon ion therapy; Proton therapy; Irradiation; Randomized trial; Hypofractionation; Heavy ion therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] PHASE II RANDOMIZED TRIAL OF SHORT COURSE HYPOFRACTIONATED RADIOTHERAPY WITH OR WITHOUT TEMOZOLOMIDE IN ELDERLY PATIENTS WITH GLIOBLASTOMA
    Madan, R.
    Thakur, S.
    Salunke, P.
    Ahuja, C.
    Khosla, D.
    Yadav, B. S.
    Kapoor, R.
    Kumar, N.
    NEURO-ONCOLOGY, 2019, 21 : 67 - 67
  • [32] THE RANDOMIZED PHASE II ARTE TRIAL: BEVACIZUMAB PLUS HYPOFRACTIONATED RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Weller, Michael
    Tabatabai, Ghazaleh
    Roelcke, Ulrich
    Hottinger, Andreas
    Joerger, Francisca
    Schmid, Andrea
    Plasswilm, Ludwig
    Schrimpf, Daniel
    Mancao, Christoph
    Capper, David
    Conen, Katrin
    Hundsberger, Thomas
    Caparrotti, Francesca
    von Moos, Roger
    Riklin, Christian
    Felsberg, Joerg
    Roth, Patrick
    Jones, David
    Pfister, Stefan M.
    Rushing, Elisabeth Jane
    Abrey, Lauren
    Reifenberger, Guido
    Held, Leonhard
    von Deimling, Andreas
    Ochsenbein, Adrian
    Wirsching, Hans-Georg
    NEURO-ONCOLOGY, 2017, 19 : 2 - 2
  • [33] Phase I/II trial of preoperative carbon ion therapy for patients with localized, resectable adenocarcinoma of the pancreas
    Yamada, S
    Kato, H
    Yasuda, S
    Yamaguchi, K
    Ohno, I
    Kitabayashi, H
    Tsujii, H
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S320 - S320
  • [34] A randomized phase II trial of dexamethasone versus prednisolone as secondary hormonal therapy in CRPC
    Venkitaraman, Ramachandran
    Thomas, Karen
    Murthy, Vedang
    Woode-Amissah, Ruth
    Dearnaley, David Paul
    Horwich, Alan
    Huddart, Robert Anthony
    De Bono, Johann Sebastian
    Parker, Chris
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [35] Phase I-II trial of hypofractionated whole breast radiation therapy for ductal carcinoma in situ (DCIS)
    Gittleman, AE
    Lymberis, SC
    MacDonald, S
    Rosenstein, BS
    DeWyngaert, J
    Formenti, SC
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S382 - S382
  • [36] Photon Volumetric Modulated Arc Therapy Versus Intensity Modulated Proton Therapy Versus Intensity Modulated Carbon Ion Therapy in the Delivery of Hypofractionated Thoracic Radiation Therapy
    Chi, A.
    Lin, L. C.
    Wen, S.
    Yan, H.
    Hsi, W. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 234 - 235
  • [37] 10-Year Update of a Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer
    Avkshtol, V.
    Li, T.
    Hallman, M. A.
    Greenberg, R.
    Price, R. A., Jr.
    Uzzo, R. G.
    Ma, C. M. C.
    Chen, D.
    Geynisman, D. M.
    Pollack, A.
    Horwitz, E. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S30 - S31
  • [38] A Phase II trial of Hypofractionated Proton Therapy in Prostate Cancer: 3-year Physician and Patient Reported Outcomes
    Philip, N.
    Pugh, T. J.
    Ye, R.
    Hwang, H.
    Wang, X.
    Shah, S. J.
    Choi, S.
    Mahmood, U.
    Nguyen, Q. N.
    Chun, S. G.
    Mayo, L. L.
    Lee, A. K.
    Tang, C.
    Anscher, M. S.
    Hoffman, K. E.
    Kuban, D. A.
    Davis, J. W.
    Troncoso, P.
    Choi, H.
    Frank, S. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E302 - E302
  • [39] Moderately hypofractionated proton beam therapy for localized prostate cancer: 5-year outcomes of a phase II trial
    Murakami, Motohiro
    Ishikawa, Hitoshi
    Sekino, Yuta
    Nishiyama, Hiroyuki
    Suzuki, Hiroyoshi
    Sugahara, Shinji
    Iizumi, Takashi
    Mizumoto, Masashi
    Okumura, Toshiyuki
    Keino, Naoto
    Iizumi, Yuichi
    Hashimoto, Koichi
    Gosho, Masahiko
    Sakurai, Hideyuki
    JOURNAL OF RADIATION RESEARCH, 2024, 65 (03) : 402 - 407
  • [40] Hypofractionated Versus Conventionally Fractionated Radiation Therapy for Prostate Cancer: Five-Year Oncologic Outcomes of the Dutch Randomized Phase 3 HYPRO Trial
    Incrocci, L.
    Wortel, R. C.
    Aluwini, S.
    Schimmel, E.
    Krol, A. D. G.
    Van der Toorn, P. P.
    de Jager, H.
    Dirkx, M.
    Alemayehu, W. Ghidey
    Heijmen, B.
    Pos, F. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (01): : 1 - 2
12345